Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia

NCT06223607 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT06223607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06223607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Recruiting
Start date
August 22, 2022
Completion date
December 22, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

baseline thrombocytopenia